We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

April 4, 2017

Ixchel Pharma, LLC. v. Biogen Inc.

Track this case

Case overview

Case Number:



California Eastern

Nature of Suit:


15:1 Antitrust Litigation


William B. Shubb



Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. January 26, 2018

    Ixchel On Last Legs With Antitrust Claims Against Biogen

    A California federal judge on Thursday gave Ixchel Pharma LLC one last chance to accuse Biogen Inc. of entering into an anti-competitive agreement with another company and undermining Ixchel’s development of a treatment for a rare neuromuscular disease, holding the latest complaint is just as deficient as its predecessor.

4 other articles on this case. View all »


To view the parties, register now.